The 5-HT1A receptor and behavioral stimulation in the rat: Effects of 8-OHDPAT on spontaneous and cocaine-induced behavior

Psychopharmacology

Volumn 177, Issue 1-2, 2004, Pages 46-54

  Carey, Robert J ^a   DePalma, Gail ^a   Damianopoulos, Ernest ^a   Müller, Christian P ^b   Huston, Joseph P ^b  

^a SYRACUSE UNIVERSITY   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

5 HT1a; 8 OHDPAT; Central zone; Cocaine; Grooming; Locomotion; Rat; Rearing; Serotonin

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN; COCAINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; UNCLASSIFIED DRUG; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN 1A RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; MOTOR ACTIVITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 12144274315     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1917-4     Document Type: Article

References (59)

1. Aghajanian GK, Bunney BS (1973) Central dopaminergic neurons: neurophysiological identification and responses to drugs. In: Snyder S, Usdin E (eds) Frontiers in catecholalmine research. Pergamon, New York, pp 643-648
2. Ahlenius S, Larsson K, Wijkstrom A (1991) Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur J Pharmacol 200:259-266
3. Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H (1981) 8-hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24:921-923
4. Bacoupoulos NG, Roth RH (1981) Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions. Brain Res 205:313-319
5. Berendsen HH, Jenck F, Broekkamp CL (1989) Selective activation of 5-HT1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav 33:821-827
6. Blanchard RJ, Shepherd JK, Armstrong J, Tauda, SF, Blanchard DC (1993) An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT. Psychopharmacology 112:55-63
7. Blier P, Lista A, de Montigny C (1993a) Differential properties of pre-and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus. 1. Effect of spiperone. J Pharmacol Exp Ther 265:7-15
8. Blier P, Lista A, de Montigny C (1993b) Differential properties of pre-and postsynaptic 5-hydroxytryptaminelA receptors in the dorsal raphe and hippocampus. II. Effect of pertussis and cholera toxins. J Pharmacol Exp Ther 265:16-23
9. Carboni E, Silvagni A, Rolando MT, Di Chiara G (2000) Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci 20:RC102
10. Carey RJ, Damianopoulos EN (1993) Activation of an apomorphine behavior pattern by cocaine: a new behavioral test for drug substitution. J Neurosci Methods 46:1-10
11. Carey RJ, Gui J (1997) A simple and reliable method for the positive identification of Pavlovian conditioned cocaine effects in open-field behavior. J Neurosci Methods 73:1-8
12. Carey RJ, Damianopoulos EN, DePalma G (2000a) 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol. Pharmacol Biochem Behav 66:863-872
13. Carey RJ, Damianopoulos EN, DePalma G (2000b) The 5-HT1A antagonist WAY 100635 can block the low dose locomotor stimulant effects of cocaine. Brain Res 862:242-246
14. Carey RJ, DePalma G, Damianopoulos E (2002a) 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms. Behav Brain Res 132:37-46
15. Carey RJ, DePalma G, Damianopoulos E (2002b) 8-OHDPAT effects upon cocaine unconditioned and conditioned behaviors: a role for drug stimulus effects. Pharmacol Biochem Behav 72:171-178
16. Chen NH, Reith MEA (1995) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systematically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem 64:1585-1597
17. Dai H, Carey RJ (1995) Behavioral interaction between the NMDA antagonist MK-801 and the dopaminergic antagonist haloperidol: support for a balance model. J Psychopharmacol 9:9-15
18. Damianopoulos EN, Carey RJ (1993) Apomorphine sensitization effects: evidence for environmentally contingent behavioral reorganization process. Pharmacol Biochem Behav 45:655-663
19. Depoortere R, Perrault G, Sanger DJ (1996) Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OHDPAT: comparison with quinpirole and apomorphine. Psychopharmacology 124:231-240
20. De La Garza R II, Cunningham KA (2000) The effects of the 5-hydroxytryptamine 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 292:610-617
21. Di Chiara G, Porceddu ML, Fratta W, Gessa GL (1977) Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 267:270-272
22. 1A receptor antagonist. Behav Brain Res 73:337-353
23. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 281:81-88
24. Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ (1999) Buspirone modulates basal and fluoxetine levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its action. Neuroscience 93:1251-1262
25. Gozlan H, El-Mestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140-142
26. Herges S, Taylor DA (1998) Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol Biochem Behav 59:595-611
27. Herges S, Taylor DA (1999a) Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY 100635 into the dorsal and median raphe nuclei of the rat. Naunyn Schmiedebergs Arch Pharmacol 360:129-134
28. Herges S, Taylor DA (1999b) Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nucleion cocaine-induced behavior in the rat. Eur J Pharmacol 374:329-340
29. Hillegaart V, Estival A, Ahlenius S (1996) Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat. Eur J Pharmacol 295:155-161
30. Ichikawa J, Ishii H, Bonaccorse S, Fowler WL, O'Laughlin IA, Meltzer HY (2001) 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521-1531
31. Karamanakos PN, Pappas P, Marselos M (2004) Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT(1A) receptors. Behav Brain Res 148:199-208
32. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661
33. Lynch MR (1991) Dissociation of autoreceptor activation and behavioral consequences of low-dose apomorphine treatment. Prog Neuropsychopharmacol Biol Psychiatry 15:689-698
34. Mattingly BA, Gotsick JE, Salamanca K (1988) Latent sensitization to apomorphine following repeated low doses. Behav Neurosci 102:553-558
35. Mattingly BA, Gotsick JE, Marin C (1989) Locomotor activity and stereotypy in rats following apomorphine treatments 1-, 3- or 7-day intervals. Pharmacol Biochem Behav 31:871-875
36. McMahon LR, Cunningham KA (2001) Antagonism of 5-hydroxytryptamine (2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357-363
37. Mignon L, Wolf WA (2002) Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat. Psychopharmacology 163:85-94
38. Molina PE, Ahmed N, Gatley J, Volkow ND, Abumrad NN (2001) L-tryptophan attenuation of the dopaminergic and behavioral responses to cocaine. Life Sci 69:1897-1906
39. Morrow BA, Roth RH (1996) Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse 23:174-181
40. Müller CP, Carey RJ, De Souza Silva MA, Jocham G, Huston JP (2002a) Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1A-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45:66-67
41. Müller CP, De Souza Silva MA, Huston JP, DePalma G, Carey RJ (2002b) The selective serotonin 1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res 134:337-346
42. 1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. Neuropharmacology 44:592-603
43. 1A-receptors attenuate cocaine-induced hyperlocomotion and the increase in hippocampal but not nucleus accumbens 5-HT. Hippocampus (in press; online-early view)
44. Nasello AG, Machado C, Bastos JF, Felicio LF (1998) Sudden darkness induces a high activity-low anxiety state in male and female rats. Physiol Behav 63:451-454
45. Pompeiano M, Palacios JM, Mengod G (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12:440-453
46. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus. Proc Natl Acad Sci U S A 92:12304-12308
47. Pradhan SN, Battacharyya AK, Pradhan S (1978) Serotoninergic manipulation of the behavioral effects of cocaine in rats. Commun Psychopharmacol 2:481-486
48. Reith MEA (1990) 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur J Pharmacol 186:327-330
49. Reith MEA, Li MY, Yan QS (1997) Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology 134:309-317
50. Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46:635-645
51. Scheel-Krüger J, Braestrup C, Nielson M, Golembiowska K, Mogilincka E (1977) Cocaine: discussion of the role of dopamine in the biochemical mechanism of action. In: Ellinwood EH, Kilbey MM (eds) Advances in behavioral biology: cocaine and other stimulants. Plenum, New York, pp 373-407
52. Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707-715
53. Sternbach MD (1991) The serotonin syndrome. Am J Psychiatry 148:705-713
54. Svingos AL, Hitzemann R (1992) 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism. Pharmacol Biochem Behav 43:871-879
55. Tricklebank MD, Forler C, Fozard JR (1984) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271-282
56. Verge D, Marcinkiewicz M, Patey A, El-Mestikawy S, Gozlan H, Hamon M (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:3474-3482
57. Walsh SL, Cunningham KA (1997) Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology 130:41-58
58. Welch JE, Farrar GE, Dunn AJ, Saphier D (1993) Central 5-HT1A receptors inhibit adrenocortical secretion. Neuroendocrinology 57:272-281
59. Welsch-Kunze S, Kuschinsky K (1990) On the possible involvement of glutamate receptors in conditioning of behavioural effects of apomorphine. Psychopharmacology 101:421-428